Literature DB >> 7893768

31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

H Fukuzako1, K Takeuchi, K Ueyama, T Fukuzako, Y Hokazono, K Hirakawa, K Yamada, T Hashiguchi, M Takigawa, T Fujimoto.   

Abstract

31P magnetic resonance spectroscopy was performed in 16 mediated schizophrenic patients with neuroleptic-resistant marked positive symptoms and in 16 healthy volunteers matched for age and sex in order to determine what changes in phosphorus metabolites are detected in such patients as compared to the controls. The schizophrenic patients showed an increased level of phosphodiesters in the bilateral medial temporal lobes. They also showed a decrease in the level of beta-ATP in the left medial temporal lobe. These findings suggest that schizophrenic patients with prominent positive symptoms refractory to neuroleptics may have a disturbance of bilateral membrane phospholipid and left-sided high-energy phosphate metabolism in the medial temporal lobe.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893768     DOI: 10.1007/bf02190375

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  30 in total

1.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins.

Authors:  D R Weinberger; K F Berman; R Suddath; E F Torrey
Journal:  Am J Psychiatry       Date:  1992-07       Impact factor: 18.112

2.  Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function.

Authors:  R G Paulman; M D Devous; R R Gregory; J H Herman; L Jennings; F J Bonte; H A Nasrallah; J D Raese
Journal:  Biol Psychiatry       Date:  1990-02-15       Impact factor: 13.382

3.  Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

Authors:  P E Barta; G D Pearlson; R E Powers; S S Richards; L E Tune
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

4.  Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain. The determination of the concentrations of phosphodiester components.

Authors:  P M Kilby; J L Allis; G K Radda
Journal:  FEBS Lett       Date:  1990-10-15       Impact factor: 4.124

5.  Increased serum phospholipase A2 activity in schizophrenia: a replication study.

Authors:  W F Gattaz; C V Hübner; T J Nevalainen; T Thuren; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

6.  Evoked potential topography in unmedicated and medicated schizophrenics.

Authors:  C Shagass; R Roemer
Journal:  Int J Psychophysiol       Date:  1991-01       Impact factor: 2.997

7.  Lateralized temporal-limbic dysfunction and psychopathology.

Authors:  P Flor-Henry
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

8.  Phospholipid bilayer contribution to 31P NMR spectra in vivo.

Authors:  E J Murphy; B Rajagopalan; K M Brindle; G K Radda
Journal:  Magn Reson Med       Date:  1989-11       Impact factor: 4.668

9.  Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging.

Authors:  T Fujimoto; T Nakano; T Takano; Y Hokazono; T Asakura; T Tsuji
Journal:  Acta Psychiatr Scand       Date:  1992-12       Impact factor: 6.392

10.  Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography.

Authors:  H Kishimoto; H Kuwahara; S Ohno; O Takazu; Y Hama; C Sato; T Ishii; Y Nomura; H Fujita; T Miyauchi
Journal:  Psychiatry Res       Date:  1987-08       Impact factor: 3.222

View more
  3 in total

1.  Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies.

Authors:  Connor S Haszto; Jeffrey A Stanley; Satish Iyengar; Konasale M Prasad
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-10-01

Review 2.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 3.  [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].

Authors:  T Wobrock; H Scherk; P Falkai
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.